Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) Accounts Payable

As of the most recent data (March 2026), ELAT shows a accounts payable of $370M. That compares with $330M in the prior-year period — up 12.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ELAT's accounts payable is now $370M (was $330M) — a 12.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is outperforming or lagging.

Tracking ELAT's accounts payable over time shows whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is scaling, shrinking, or reshaping that part of the business. The current reading is $370M That compares with $330M in the prior-year period — up 12.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $370M) with ownership activity and broader fundamentals.

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s accounts payable is $370M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.